Abstract
BackgroundPD-L1 IHC 22C3 pharmDx is an FDA-approved companion diagnostic for pembrolizumab across multiple tumor types designed for use on the Autostainer Link 48 (AL48). Many pathology laboratories do not have...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have